Showing 1 - 10 of 12,713
Cross-border acquisitions by Indian companies have increased tremendously, especially during the last two decades, and the pharmaceutical industry is one of the top acquiring industries. This study verifies the relationship between cross-border acquisitions and shareholders’ wealth in the...
Persistent link: https://www.econbiz.de/10013471449
Persistent link: https://www.econbiz.de/10013342926
Persistent link: https://www.econbiz.de/10012182271
Persistent link: https://www.econbiz.de/10009310353
Seasonality is a repeatable tendency of a financial instrument to move in relation to a particular influencing factor. That factor could be the time of year, the year of a decade, changes in interest rates, inflation, energy prices, etc. We focus on stock price action and seasonal cycles derived...
Persistent link: https://www.econbiz.de/10013088761
paper examines the short-run abnormal returns to India based mergers and acquisitions focusing on the pharmaceutical …
Persistent link: https://www.econbiz.de/10013066232
examine the existence of risk anomaly in the National Stock Exchange, India, and in particular providing a comparative … analysis on the behavior of the pharmaceutical sector in India …
Persistent link: https://www.econbiz.de/10012840183
Persistent link: https://www.econbiz.de/10012583993
India, listed under NIFTY100, using the ARIMA model. A sample size of 782 time-series observations from January 1, 2017, to …
Persistent link: https://www.econbiz.de/10013249306
The paper examined the impact of converging with IFRS, on stock market performance of 12 pharmaceuticals companies listed in S&P BSE 100. The time frame of six years from 2013 to 2018 was selected and Ordinary Least Square (OLS) regression model was used for the analysis. The result revealed...
Persistent link: https://www.econbiz.de/10012828614